TELA - TELA Bio Inc. (TELA) Q4 2023 Earnings Call Transcript
2024-03-21 19:38:03 ET
TELA Bio, Inc. (TELA)
Q4 2023 Earnings Conference Call
March 21, 2024, 04:30 PM ET
Company Participants
Louisa Smith - Vice President, Gilmartin Group
Antony Koblish - Co-Founder, President and Chief Executive Officer
Roberto Cuca - Chief Operating Officer and Chief Financial Officer
Conference Call Participants
Frank Takkinen - Lake Street Capital Markets
Caitlin Cronin - Canaccord Genuity
Michael Sarcone - Jefferies
David Turkaly - JMP Securities
Presentation
Operator
Good afternoon ladies and gentlemen and welcome to the TELA Bio Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder this conference call is being recorded.
I would now like to turn the conference over to Louisa Smith from the Gilmartin Group.
Louisa Smith
Thank you, Michelle, and good afternoon everyone. Earlier today, TELA Bio released financial results for the fourth quarter and full year 2023. A copy of the press release is available on the company’s website. Joining me on today’s call are Tony Koblish, President and Chief Executive Officer; and Roberto Cuca, Chief Operating Officer and Chief Financial Officer.
Before we begin, I’d like to remind you that during this conference call, the company may make projections and forward-looking statements regarding future events. We encourage you to review the company’s past and future filings with the SEC including, without limitation, the company’s Annual Report on Form 10-K and quarterly reports on Form 10-Qs, which identify the specific factors that may cause actual results or events to differ materially from those described in these forward-looking statements....
TELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript